STEROID REFRACTORY GVHD

Clinical trials for STEROID REFRACTORY GVHD explained in plain language.

Never miss a new study

Get alerted when new STEROID REFRACTORY GVHD trials appear

Sign up with your email to follow new studies for STEROID REFRACTORY GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for transplant patients fighting a devastating rejection

Disease control Recruiting now

This study is testing a new drug called RLS-0071 for patients who develop a severe immune reaction (graft-versus-host disease) after a stem cell transplant and do not get better with standard steroid treatment. Researchers will give different doses to hospitalized patients to see…

Matched conditions: STEROID REFRACTORY GVHD

Phase: PHASE2 • Sponsor: ReAlta Life Sciences, Inc. • Aim: Disease control

Last updated Mar 17, 2026 13:08 UTC

STEROID REFRACTORY GVHD

Get alerted when new STEROID REFRACTORY GVHD trials appear

New hope for transplant patients fighting a devastating rejection